FDA NARROWS US INDICATIONS FOR THE ANTIEMETIC DOXYLAMINE + PYRIDOXINE Newsletter Article 09 February 2013 Pages: 2 - 2
US NIH STATEMENT ON THROMBOLYTIC THERAPY IN THROMBOSIS Newsletter Article 09 February 2013 Pages: 2 - 3
SPECTINOMYCIN IS FIRST CHOICE FOR GONORRHOEA IN SOME AREAS Newsletter Article 09 February 2013 Pages: 4 - 4
PLATELET AGGREGATION INHIBITION: is thromboxane receptor blockade better than thromboxane synthesis inhibition? Newsletter Article 09 February 2013 Pages: 6 - 6
TWO MULTICENTRE COMPARISONS OF PIROXICAM AND INDOMETHACIN Newsletter Article 09 February 2013 Pages: 9 - 10
LONG TERM BROMOCRIPTINE THERAPY IS OF VALUE IN ACROMEGALY Newsletter Article 09 February 2013 Pages: 10 - 10
PUVA DOES NOT INCREASE THE COST OF TREATING PSORIASIS Newsletter Article 09 February 2013 Pages: 10 - 10
LOW DOSE PROGESTOGEN PRODUCES AN ADEQUATE SECRETORY ENDOMETRIUM Newsletter Article 09 February 2013 Pages: 12 - 12
PROPRANOLOL EVALUATED IN PATIENTS WITH RHEUMATOID ARTHRITIS Newsletter Article 09 February 2013 Pages: 13 - 13
THIOTHIXENE PLASMA LEVELS AND RESPONSE IN SCHIZOPHRENIA Newsletter Article 09 February 2013 Pages: 14 - 14
ASPIRIN AFFECTS LIPIDS, PLATELETS, AND BLEEDING TIME Newsletter Article 09 February 2013 Pages: 14 - 14
UNBOUND THIORIDAZINE LEVELS IN CSF NEARLY TWICE THOSE IN SERUM Newsletter Article 09 February 2013 Pages: 15 - 15
VASOPRESSIN LEVELS MAY RISE, BUT BP REMAINS UNCHANGED Newsletter Article 09 February 2013 Pages: 15 - 15
LORCAINIDE: A NEW THERAPEUTIC BOON FOR VENTRICULAR TACHYCARDIA Newsletter Article 09 February 2013 Pages: 16 - 16
β-BLOCKERS IN HYPERTHYROIDISM: Update to Issue No. 162 Newsletter Article 09 February 2013 Pages: 19 - 20